ICU Management & Practice, Volume 23 - Issue 1, 2023

Biomarkers are quantifiable indicators of physiological or pathological processes in the body. They can be more effectively utilised in intensive care by improving standardised protocols for biomarker testing and interpretation. Join our panellists as they discuss the use of Biomarkers in critical care and where and how biomarkers can provide valuable diagnostic, prognostic and therapeutic value. 



Moderator

Jean-Louis Vincent (MODERATOR)

Editor-in-Chief

ICU Management & Practice

Professor

Department of Intensive Care

Erasme Hospital

Université libre de Bruxelles

Brussels, Belgium



Panellists & Topics


Antonio Artigas Raventós

Professor

Critical Care Center

Hospital Universitari Parc Taulí

Institut d'Investigació i Innovació Parc Taulí

Univeristat Autonoma de Barcelona

Sabadell, Spain

Topic:Pulmonary or Systemic Biomarkers in ARDS


Michael S Niederman

Professor of Clinical Medicine

Division of Pulmonary and

Critical Care

Weill Cornell Medical College

New York, NY

Topic: Overview of Biomarkers in Sepsis and Pneumonia


Ryan C Maves

Professor of Medicine and Anesthesiology 

Sections of Infectious Diseases and Critical Care Medicine 

Wake Forest University School of Medicine 

Winston-Salem, North Carolina, USA 

Topic: Biomarkers, Procalcitonin and its Limitations


Joanna Poole

Anaesthetic Registrar

North Bristol NHS Trust

UK

Topic:Translating Biomarkers from Bench to Bedside


«« Two Shocks Better Than One?


European Guidelines: Management of Bleeding, Coagulopathy Following Trauma »»